CBOE · US Equities - Quant Strat · USA
The companies inside CSM trade at about what we estimate they are worth. We could give a verdict on 90% of the fund's weight: 309 holdings as reported to the SEC at 31 May 2026.
Where the money is: 23% in companies in the buy zone, 8% about fairly valued, 58% overvalued, 10% without a verdict.
The ten largest holdings, with our verdict on each:
Its expense ratio is 0.45% a year: on $10,000 held flat that is $450 over 10 years and $900 over 20.